The SCN5A mutation T1620M associated with Brugada syndrome causes enhanced intermediate inactivation of Na+ channels, supporting the hypothesis that the syndrome is partly caused by functionally reduced Na+ current.
Answers are grounded in this paper and cite their sources.
Supports SCN5A T1620M mechanism in Brugada syndrome; leaves open clinical translation pending human validation.
Brugada syndrome is an inherited cardiac disease that causes sudden death related to idiopathic ventricular fibrillation in a structurally normal heart. The disease is characterized by ST-segment elevation in the right precordial ECG leads and is frequently accompanied by an apparent right bundle-branch block. The biophysical properties of the SCN5A mutation T1620M associated with Brugada syndrome were examined for defects in intermediate inactivation (I:(M)), a gating process in Na(+) channels with kinetic features intermediate between fast and slow inactivation. Cultured mammalian cells expressing T1620M Na(+) channels in the presence of the human beta(1) subunit exhibit enhanced intermediate inactivation at both 22 degrees C and 32 degrees C compared with wild-type recombinant human heart Na(+) channels (WT-hH1). Our findings support the hypothesis that Brugada syndrome is caused, in part, by functionally reduced Na(+) current in the myocardium due to an increased proportion of Na(+) channels that enter the I:(M) state. This phenomenon may contribute significantly to arrhythmogenesis in patients with Brugada syndrome. The full text of this article is available at http://www.circresaha.org.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: